The size of the global resveratrol market is expected to be worth USD 100.64 million in 2024 and grow at a CAGR of 8.40% from 2024 to 2032 to achieve USD 191.87 million by 2032.
Resveratrol is a flavonoid group flavanol. It is a phytoalexin that is naturally synthesized by various plants when attacked by various pathogens such as bacteria and fungi. Resveratrol is found in a variety of plants and fruits such as red grapes, peanuts, blueberries, Morus alba, raspberries, eucalyptus and peppers. Resveratrol is widely used in pharmaceutical, cosmetic and dietary supplement applications.
Resveratrol is widely used in the pharmaceutical industry because it has the ability to heal and manage a variety of diseases such as cancer, cardio-vascular disease, diabetes, and neurological diseases. The popularity and use of antioxidants in the cosmetic and dietary supplement industries has skyrocketed. Resveratrol is a potent antioxidant, making it a unique candidate for providing desirable anti-aging effects in cosmetics. It may also have a variety of beneficial effects when taken as a dietary supplement, such as lowering the risk of cardio-vascular disease and others.
The main aspect of accelerating market growth is the increasing demand for dietary supplements. Demand growth is driven primarily by the prevalence of many health problems and lifestyle changes among consumers around the world. Resveratrol Market Trend shows it is primarily used in dietary supplements due to the demand for natural products found in red wine, grapes and other botanical sources. In addition, increasing acceptance of health foods is another important parameter that drives global market growth. The growing health awareness of consumers around the world has led to a surge in demand for these health food supplements. The presence of antioxidants and other nutrients can prevent a variety of health problems. It is also often used as a natural preservative and food additive in a variety of foods and beverages. Increasing awareness of the benefits of resveratrol is expected to spur market growth during the evaluation period.
Several factors are driving market growth, but certain aspects can limit market growth. The lack of clinical evidence to support its therapeutic use is expected to impede the growth of the resveratrol market. In addition, discoveries and innovations in the chemical and pharmaceutical industries offer a new type of resveratrol. This can make you vulnerable to potential threats in the coming years.
REPORT METRIC |
DETAILS |
Market Size Available |
2023 to 2032 |
Base Year |
2023 |
Forecast Period |
2024 to 2032 |
CAGR |
8.40% |
Segments Covered |
By Product Type, Application, Form, and Region |
Various Analyses Covered |
Global, Regional & Country Level Analysis; Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
Market Leaders Profiled |
Koninklijke DSM N.V., Evolva Holding SA, Sabinsa Corporation, Lonza Group AG, Maypro, Laurus Labs Limited, JF Natural, Great Forest Biomedical Ltd, Chengdu Yazhong Bio-pharmaceutical Co., Ltd and Others. |
Based on product type, the global resveratrol market is divided into synthetic and natural resveratrol. The natural resveratrol segment secured the top position in the global resveratrol market in terms of revenue share in 2021. The main factor that causes this is increased consumer awareness of the benefits of taking natural resveratrol. Peanuts, blueberries, grape seeds and other foods contain natural resveratrol, which contributes significantly to the growth of the segment.
Based on the application, the global resveratrol market will be divided into cosmetics, dietary supplements and pharmaceuticals. The dietary supplement segment is expected to dominate the global resveratrol market by 2022. The main aspect that drives segment growth is the increasing demand for dietary supplements with many benefits such as improved insulin sensitivity, relief of joint pain, regulation of cholesterol levels and lowering blood pressure.
Based on the form, the market is divided into liquids and powders. The power segment is expected to gain the largest revenue share in the resveratrol market in 2020 and maintain its position for the duration of the forecast.
The North American region is expected to lead the global resveratrol market in the coming years. The growth of the regional market is mainly due to the increased consumption of resveratrol as a dietary supplement by consumers. In addition, resveratrol is known to prevent heart disease, which catalyzes market growth.
The Asia Pacific resveratrol market is projected to record the highest growth rates during the valuation period. The growth of the regional market is mainly due to the growing consumer awareness of the benefits of resveratrol. Furthermore, the region's growing ageing population is expected to catalyze regional market growth in the coming years.
Major key players in the global resveratrol market are Koninklijke DSM N.V., Evolva Holding SA, Sabinsa Corporation, Lonza Group AG, Maypro, Laurus Labs Limited, JF Natural, Great Forest Biomedical Ltd, Chengdu Yazhong Bio-pharmaceutical Co., Ltd and Others.
DSM Acquires Dairy Flavor Producer First Choice Ingredients for US $ 453 million-
By Product Type
By Application
By Form
By Region
Frequently Asked Questions
The global resveratrol market is expected to grow at an 8.4 percent CAGR during the forecast period.
One of the major factors expected to drive market growth during the forecast period is the increasing use of resveratrol in cosmetics and dietary supplements.
Some of the major factors that are expected to impede market growth during the forecast period are gastrointestinal upset, nausea, headache, and fatigue associated with resveratrol.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region